Synthetic tetrapeptide studied in telomerase-activation and longevity literature.
What it is
Epithalon (Epitalon) is a synthetic tetrapeptide studied in telomerase-activation and longevity literature, historically linked to Khavinson pineal bioregulator research. Preclinical work examines telomere-related and aging biomarkers.
Also known as
Epitalon · Epithalamin-related tetrapeptide · Ala-Glu-Asp-Gly
Overview
Epithalon (Epitalon) is a synthetic tetrapeptide studied in telomerase-activation and longevity literature, historically linked to Khavinson pineal bioregulator research. Preclinical work examines telomere-related and aging biomarkers.
It is used in laboratory aging models as a short-peptide tool, not as an established human longevity treatment. Left Turn Adventures supplies this compound for laboratory and research use only.
Proven benefits
Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.
Telomerase and telomere-length research endpoints
• Pineal/bioregulator aging markers in preclinical designs
• Oxidative-stress and circadian-adjacent readouts where studied
• Longevity-model survival and biomarker measures
• Short-peptide gerontology pharmacology (Khavinson-linked)
Results timeline
Note: Illustrative research-observation windows — not a clinical schedule. No dosing.
Week 1–2: Early signaling and behavioral endpoints in acute neuro models; exposure establishing.
Week 3–4: Clearer cognitive, stress, or neuroprotective markers in short preclinical windows.
Month 2–3: More stable memory, focus, or neuroplasticity-related endpoints in extended designs.
Month 3–6: Sustained neuro and aging-adjacent observations where longer protocols are used.
The catalog, not a clinic
For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.